Boston Scientific's new deep brain stimulation software gets FDA nod
Novo Nordisk turns RNAi research up to Eleven with new biotech pact
Merck KGaA invests €23 million to expand cell culture media production
FDA grants approval for Veklury use in Covid-19 patients with severe renal impairment
*please scroll down for all the latest news*
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraudimage: 
Original Article
Jul 17 2023 – Boston Scientific’s new deep brain stimulation software gets FDA nod
